ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Sage Therapeutics Inc

Sage Therapeutics Inc (SAGE)

5.29
-0.25
( -4.51% )
Updated: 04:27:55

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.87M3.29M2.47M2.72M77.97M7.9M8.65M11.87M
Operating Income -153.9M-155.47M-170.46M-211.85M-42.07M-117.68M-111.3M-101.2M
Pre Tax Income -147.15M-146.83M-160.33M-201.63M-32.71M-108.48M-102.85M-93.55M
Net Income -147.15M-146.83M-160.33M-201.63M-32.71M-108.48M-102.85M-93.55M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -153.94M-155.66M-170.5M-211.9M-42.17M-117.69M-111.3M-101.19M
EBITDA -153.61M-155.15M-170.13M-211.52M-41.67M-117.34M-110.99M-100.95M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0090.27M6.87M1.11B6.31M7.69M86.46M
Operating Income -160.16M-273.16M-393.24M-708.12M596.23M-460.91M-546.99M-579.85M
Pre Tax Income -158.99M-270.12M-372.88M-680.24M606.07M-457.89M-532.78M-541.49M
Net Income -158.99M-270.12M-372.88M-680.24M606.07M-457.89M-532.78M-541.49M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.271-6.431-7.953-13.11310.394-7.769-8.953-9.03
EBIT -160.2M-273.22M-393.22M-708.04M596.48M-460.78M-546.97M-580.23M
EBITDA -159.86M-272.62M-392.1M-705.84M598.86M-456.73M-545.87M-578.46M